Revenue ($USD) : $1,596,673,000
R&D spend : $63,771,000
Employees : 10,500
Fiscal year end : 12/31/2023
CEO : Joseph Dziedzic

www.integer.net

Integer is one of the world’s largest medical device contract manufacturers, serving the cardiac rhythm management, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. Integer’s stock price climbed more than 23% in 2024 as of mid-August. The company expects above-market sales growth of 9–11% for full year 2024. –CN